RMR Wealth Builders Invests $68,000 in Metlife Inc (NYSE:MET)

RMR Wealth Builders bought a new stake in Metlife Inc (NYSE:MET) during the second quarter, according to its most recent filing with the SEC. The firm bought 1,864 shares of the financial services provider’s stock, valued at approximately $68,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Public Employees Retirement Association of Colorado increased its position in Metlife by 15.4% in the 1st quarter. Public Employees Retirement Association of Colorado now owns 146,582 shares of the financial services provider’s stock worth $4,481,000 after buying an additional 19,525 shares during the period. First Manhattan Co. raised its stake in Metlife by 56.7% during the 1st quarter. First Manhattan Co. now owns 3,950 shares of the financial services provider’s stock valued at $120,000 after purchasing an additional 1,430 shares during the last quarter. Bartlett & Co. LLC bought a new stake in Metlife in the 1st quarter valued at $117,000. Oppenheimer & Co. Inc. grew its position in Metlife by 44.2% in the 1st quarter. Oppenheimer & Co. Inc. now owns 72,064 shares of the financial services provider’s stock worth $2,203,000 after purchasing an additional 22,093 shares during the last quarter. Finally, Cetera Advisor Networks LLC increased its holdings in shares of Metlife by 82.9% during the 1st quarter. Cetera Advisor Networks LLC now owns 24,468 shares of the financial services provider’s stock worth $748,000 after purchasing an additional 11,088 shares during the period. Hedge funds and other institutional investors own 74.92% of the company’s stock.

In related news, Director Catherine R. Kinney sold 3,657 shares of Metlife stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $39.50, for a total value of $144,451.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.07% of the company’s stock.

Metlife stock traded up $0.52 during trading hours on Wednesday, hitting $38.03. 200,999 shares of the stock were exchanged, compared to its average volume of 6,750,636. The stock has a market capitalization of $34.05 billion, a P/E ratio of 4.95, a P/E/G ratio of 2.21 and a beta of 1.30. The business’s 50-day moving average is $38.53 and its two-hundred day moving average is $35.89. The company has a debt-to-equity ratio of 0.20, a quick ratio of 0.16 and a current ratio of 0.16. Metlife Inc has a 12 month low of $22.85 and a 12 month high of $53.28.

Metlife (NYSE:MET) last released its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.83 EPS for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.07). Metlife had a return on equity of 7.71% and a net margin of 10.65%. On average, equities analysts predict that Metlife Inc will post 5.54 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Monday, September 14th. Stockholders of record on Tuesday, August 4th were issued a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a dividend yield of 4.84%. The ex-dividend date of this dividend was Monday, August 3rd. Metlife’s payout ratio is presently 30.11%.

Several brokerages recently commented on MET. Morgan Stanley raised their target price on Metlife from $44.00 to $46.00 and gave the stock an “overweight” rating in a research report on Thursday, August 20th. Bank of America began coverage on shares of Metlife in a report on Monday, June 1st. They set a “buy” rating for the company. Wells Fargo & Company reiterated a “buy” rating and set a $45.00 target price on shares of Metlife in a research report on Thursday, August 6th. Zacks Investment Research upgraded shares of Metlife from a “sell” rating to a “hold” rating and set a $45.00 price target for the company in a research note on Tuesday, June 9th. Finally, Argus reiterated a “buy” rating on shares of Metlife in a research note on Wednesday, August 19th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $42.25.

Metlife Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Featured Article: What is a Futures Contract?

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.